p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment
- Department of Radiation Oncology, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China) and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Putz City, Chia-Yi Hsien, Taiwan (China)
- Department of Radiation Oncology, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China)
- Department of Urology, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China)
- Department of Pathology, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China)
- Division of Surgical Oncology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA (United States)
- Graduate Institute of Clinical Medical Sciences, Chang Gung University, Putz City, Chia-Yi Hsien, Taiwan (China)
- Department of Internal Medicine, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China)
- Department of Hematology and Oncology, Chang Gung Memorial Hospital, Putz City, Chia-Yi Hsien, Taiwan (China)
Purpose: The potential roles of peroxiredoxin (Prx) I in carcinogenesis and treatment have been explored. Our previous study revealed differences between A549 (functional p53) and H1299 (null p53) Prx I antisense transfectants. The discrepancy might have resulted from the p53 status. In this study, we further investigated the role of Prx I and p53 on lung cancer growth and the response to treatment in vitro and in vivo. Methods: We established stable A549 and H1299 transfectants with Prx I antisense and p53, respectively. We then examined their characteristics in vitro and used nude mice xenografts of these cell lines to compare their capacity for tumor invasion and spontaneous metastasis and their sensitivity to radiotherapy. Results: Increased reactive oxygen species caused by lower Prx I activity induced p53 expression. In lethal stress, the augmentation of reactive oxygen species was partially reversed by blocking p53 in A549 with Prx I antisense. We demonstrated the potential contribution of p53-dependent mechanisms to inhibit lung tumor growth and increase radiosensitization using H1299 transfected with p53 in vitro and in vivo. An increased p53 level attenuated the capacity of the cells for metastasis by decreasing vascular endothelial growth factor and induced radiosensitization by increased apoptosis and cell senescence and by regulating intracellular reactive oxygen species. Conclusion: These results suggest that p53 status has an important role in the tumor-inhibiting and radiosensitizing effects of decreasing Prx I. Both Prx I and p53 may be powerful prognosticators for lung cancer.
- OSTI ID:
- 20850272
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 66, Issue 5; Other Information: DOI: 10.1016/j.ijrobp.2006.07.1372; PII: S0360-3016(06)02729-5; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Role of Peroxiredoxin I in Rectal Cancer and Related to p53 Status
Attenuation of the DNA Damage Response by Transforming Growth Factor-Beta Inhibitors Enhances Radiation Sensitivity of Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo